Apyx Medical Co. (NASDAQ:APYX) Short Interest Update

Apyx Medical Co. (NASDAQ:APYX) was the recipient of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 371,100 shares, a decline of 47.5% from the March 31st total of 706,700 shares. Based on an average daily volume of 154,700 shares, the short-interest ratio is presently 2.4 days. Currently, 1.3% of the company’s shares are short sold.

Apyx Medical Price Performance

APYX stock opened at $1.48 on Friday. The stock has a market cap of $51.27 million, a PE ratio of -2.74 and a beta of 1.09. The company has a current ratio of 5.52, a quick ratio of 4.74 and a debt-to-equity ratio of 1.23. Apyx Medical has a 12 month low of $1.21 and a 12 month high of $7.97. The company has a 50-day moving average price of $1.68 and a 200 day moving average price of $2.13.

Apyx Medical (NASDAQ:APYX) last posted its quarterly earnings results on Thursday, March 21st. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.06). Apyx Medical had a negative net margin of 35.75% and a negative return on equity of 54.90%. The business had revenue of $14.66 million during the quarter, compared to the consensus estimate of $14.40 million. Equities research analysts anticipate that Apyx Medical will post -0.74 earnings per share for the current year.

Institutional Investors Weigh In On Apyx Medical

Several large investors have recently modified their holdings of the business. Silverberg Bernstein Capital Management LLC raised its stake in shares of Apyx Medical by 1.2% during the 1st quarter. Silverberg Bernstein Capital Management LLC now owns 621,387 shares of the company’s stock worth $845,000 after acquiring an additional 7,507 shares in the last quarter. Kingsview Wealth Management LLC bought a new position in shares of Apyx Medical during the 4th quarter worth approximately $32,000. ProVise Management Group LLC bought a new position in shares of Apyx Medical during the 4th quarter worth approximately $35,000. Barclays PLC bought a new position in shares of Apyx Medical during the 3rd quarter worth approximately $46,000. Finally, Jump Financial LLC bought a new position in shares of Apyx Medical during the 3rd quarter worth approximately $48,000. Institutional investors own 55.33% of the company’s stock.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.